Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity-Reference-Cited by-同舟云学术

Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity

Published:2007-09-04 Issue:9 Volume:117 Page:2638-2648
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Graff Jeremy R.,Konicek Bruce W.,Vincent Thomas M.,Lynch Rebecca L.,Monteith David,Weir Spring N.,Schwier Phil,Capen Andrew,Goode Robin L.,Dowless Michele S.,Chen Yuefeng,Zhang Hong,Sissons Sean,Cox Karen,McNulty Ann M.,Parsons Stephen H.,Wang Tao,Sams Lillian,Geeganage Sandaruwan,Douglass Larry E.,Neubauer Blake Lee,Dean Nicholas M.,Blanchard Kerry,Shou Jianyong,Stancato Louis F.,Carter Julia H.,Marcusson Eric G.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference45 articles.

1. eIF-4E expression and its role in malignancies and metastases

2. eIF4E – from translation to transformation

3. Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin

4. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway

5. The tor pathway: a target for cancer therapy

Cited by 334 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside;Cancers;2024-08-23

2. eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production;Nucleus;2024-06-16

3. RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities;Critical Reviews in Oncology/Hematology;2024-03

4. Pharmacodynamic evaluation of AUM001/tinodasertib, an oral inhibitor of mitogen-activated protein kinase (MAPK)-interacting protein kinase 1, 2 (MNK1/2) in preclinical models and tissues from a Phase 1 clinical study;2024-02-29

5. MNK, mTOR or eIF4E-selecting the best anti-tumor target for blocking translation initiation;European Journal of Medicinal Chemistry;2023-11